Genetic Breakthrough Reveals Early Heart Risks
- A new study presented at the American Heart Association (AHA) 2025 Scientific Sessions demonstrates that incorporating polygenic risk scores (PRS) considerably improves the accuracy of predicting cardiovascular disease...
- Polygenic risk scores are a type of genetic test that estimates a person's risk of developing a disease based on the combined effect of many genetic variants. Unlike...
- Traditionally,CVD risk assessment relies on factors like age,sex,blood pressure,cholesterol levels,and family history.
“`html
Polygenic Risk Scores enhance Cardiovascular Disease Prediction, New AHA 2025 Study Shows
Table of Contents
Published November 11, 2023, at 4:07 PM PST
A new study presented at the American Heart Association (AHA) 2025 Scientific Sessions demonstrates that incorporating polygenic risk scores (PRS) considerably improves the accuracy of predicting cardiovascular disease (CVD) risk. The research, conducted by Genomics researchers, offers a potential pathway too more personalized and proactive cardiovascular healthcare.
What are Polygenic Risk Scores?
Polygenic risk scores are a type of genetic test that estimates a person’s risk of developing a disease based on the combined effect of many genetic variants. Unlike tests that focus on single genes with large effects, PRS consider thousands or even millions of common genetic variations, each contributing a small amount to overall risk. The National Human Genome Research Institute provides a detailed explanation of PRS.
Traditionally,CVD risk assessment relies on factors like age,sex,blood pressure,cholesterol levels,and family history. While useful, these methods don’t account for an individual’s underlying genetic predisposition.
Key findings from the AHA 2025 Study
The study, presented at the AHA 2025 Scientific Sessions, involved[[[[Note: Specific details about the study population size, demographics, and specific CVD endpoints were not provided in the source. This section will be updated with those details as they become available.]. researchers found that adding PRS to conventional risk factors led to a statistically important improvement in identifying individuals who would ultimately develop CVD.
Specifically, the study showed that[[[[Note: Quantitative data on the improvement in accuracy (e.g., increased sensitivity, specificity, or area under the curve) were not provided in the source. This section will be updated with those details as they become available.]. This suggests that PRS could help clinicians better target preventative interventions, such as lifestyle modifications or medication, to those who would benefit most.
Implications for Cardiovascular Healthcare
The integration of PRS into clinical practice has the potential to revolutionize cardiovascular healthcare. By identifying individuals at higher genetic risk, doctors can implement earlier and more aggressive preventative strategies. This could lead to a reduction in the incidence of heart attacks,strokes,and other CVD events.
However, several challenges remain before PRS can be widely adopted. These include:
- Cost and Accessibility: Genetic testing can be expensive, and access may be limited for some populations.
- Ethnic Diversity: Most PRS have been developed using data from individuals of European ancestry. Thier accuracy in other populations may be lower. Research published in Nature Medicine highlights the importance of diverse genomic datasets for accurate PRS.
- Clinical Implementation: Developing clear guidelines for how to interpret and use PRS in clinical decision-making is crucial.
- Patient Education: Patients need to understand the implications of their PRS results and how they can use this information to improve their health.
Timeline of cardiovascular Disease Risk Prediction
| Year | Milestone |
|---|---|
| 1961 |
|